Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1991 Dec;44(12):983–989. doi: 10.1136/jcp.44.12.983

Quantitative interrelations of Lewis antigens in normal mucosa and transitional cell bladder carcinomas.

C Limas 1
PMCID: PMC494965  PMID: 1791214

Abstract

The factors regulating the expression of the Lewis blood group related antigens in tissues have yet to be clarified. In an attempt to resolve some of the existing controversies the quantitative interrelationship of the Le(a), Le(b), X and Y antigens in normal urothelium and transitional cell carcinomas (TCC) was studied using biopsy specimens derived from 22 patients whose ABO and Lewis red blood cell phenotype was known. A quantitative scale was devised to encompass both the extent and intensity of the immunohistochemical reactivity in one numerical value (score). The expression of these four antigens in the normal urothelium followed a characteristic pattern that is related to but not identical with the red blood cell phenotype. An excess of Le(b) and Y in the urothelium correlated with the Le(a-b+) red blood cell phenotype, while a relative increase in Le(a) and X (at the expense of Le(b) and Y) was associated with the Le(a+b-) red blood cell phenotype. This pattern can be accounted for by the combined effects of differential gene expression and substrate availability. The quantitative comparison of the antigenic make-up of TCCs with the corresponding normal tissue phenotype shows consistent trends, suggesting that the changes associated with neoplasia derive primarily from the suppression of specific gene products and, secondarily, from altered competitive substrate utilisation.

Full text

PDF
983

Images in this article

984Image
on p.984
986Image
on p.986
986Image
on p.986
987Image
on p.987
987Image
on p.987

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cordon-Cardo C., Lloyd K. O., Finstad C. L., McGroarty M. E., Reuter V. E., Bander N. H., Old L. J., Melamed M. R. Immunoanatomic distribution of blood group antigens in the human urinary tract. Influence of secretor status. Lab Invest. 1986 Oct;55(4):444–454. [PubMed] [Google Scholar]
  2. Cordon-Cardo C., Reuter V. E., Finstad C. L., Sheinfeld J., Lloyd K. O., Fair W. R., Melamed M. R. Blood group-related antigens in human kidney: modulation of Lewis determinants in renal cell carcinoma. Cancer Res. 1989 Jan 1;49(1):212–218. [PubMed] [Google Scholar]
  3. Cordon-Cardo C., Reuter V. E., Lloyd K. O., Sheinfeld J., Fair W. R., Old L. J., Melamed M. R. Blood group-related antigens in human urothelium: enhanced expression of precursor, LeX, and LeY determinants in urothelial carcinoma. Cancer Res. 1988 Jul 15;48(14):4113–4120. [PubMed] [Google Scholar]
  4. Decenzo J. M., Howard P., Irish C. E. Antigenic deletion and prognosis of patients with stage A transitional cell bladder carcinoma. J Urol. 1975 Dec;114(6):874–878. doi: 10.1016/s0022-5347(17)67163-5. [DOI] [PubMed] [Google Scholar]
  5. Holmes E. H., Ostrander G. K., Clausen H., Graem N. Oncofetal expression of Lex carbohydrate antigens in human colonic adenocarcinomas. Regulation through type 2 core chain synthesis rather than fucosylation. J Biol Chem. 1987 Aug 15;262(23):11331–11338. [PubMed] [Google Scholar]
  6. Juhl B. R., Hartzen S. H., Hainau B. Lewis a antigen in transitional cell tumors of the urinary bladder. Cancer. 1986 Jul 15;58(2):222–228. doi: 10.1002/1097-0142(19860715)58:2<222::aid-cncr2820580204>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  7. Kim Y. S., Itzkowitz S. H., Yuan M., Chung Y., Satake K., Umeyama K., Hakomori S. Lex and Ley antigen expression in human pancreatic cancer. Cancer Res. 1988 Jan 15;48(2):475–482. [PubMed] [Google Scholar]
  8. LEWIS M., KAITA H., CHOWN B. The blood groups of a Japanese population. Am J Hum Genet. 1957 Dec;9(4):274–283. [PMC free article] [PubMed] [Google Scholar]
  9. Limas C. Detection of urothelial Lewis antigens with monoclonal antibodies. Am J Pathol. 1986 Dec;125(3):515–523. [PMC free article] [PubMed] [Google Scholar]
  10. Limas C., Lange P. H. Lewis antigens in normal and neoplastic urothelium. Am J Pathol. 1985 Oct;121(1):176–183. [PMC free article] [PubMed] [Google Scholar]
  11. Limas C., Lange P., Fraley E. E., Vessella R. L. A, B, H antigens in transitional cell tumors of the urinary bladder: correlation with the clinical course. Cancer. 1979 Dec;44(6):2099–2107. doi: 10.1002/1097-0142(197912)44:6<2099::aid-cncr2820440621>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  12. Lloyd K. O., Larson G., Strömberg N., Thurin J., Karlsson K. A. Mouse monoclonal antibody F-3 recognizes the difucosyl type-2 blood group structure. Immunogenetics. 1983;17(5):537–541. doi: 10.1007/BF00696877. [DOI] [PubMed] [Google Scholar]
  13. Marcus D. M., Cass L. E. Glycosphingolipids with Lewis blood group activity: uptake by human erythrocytes. Science. 1969 May 2;164(3879):553–555. doi: 10.1126/science.164.3879.553. [DOI] [PubMed] [Google Scholar]
  14. Mollicone R., Bara J., Le Pendu J., Oriol R. Immunohistologic pattern of type 1 (Lea, Leb) and type 2 (X, Y, H) blood group-related antigens in the human pyloric and duodenal mucosae. Lab Invest. 1985 Aug;53(2):219–227. [PubMed] [Google Scholar]
  15. Oriol R., Le Pendu J., Mollicone R. Genetics of ABO, H, Lewis, X and related antigens. Vox Sang. 1986;51(3):161–171. doi: 10.1111/j.1423-0410.1986.tb01946.x. [DOI] [PubMed] [Google Scholar]
  16. Orntoft T. F., Wolf H., Clausen H., Hakomori S., Dabelsteen E. Blood group ABO and Lewis antigens in fetal and normal adult bladder urothelium: immunohistochemical study of type 1 chain structures. J Urol. 1987 Jul;138(1):171–176. doi: 10.1016/s0022-5347(17)43038-2. [DOI] [PubMed] [Google Scholar]
  17. Orntoft T. F., Wolf H., Watkins W. M. Activity of the human blood group ABO, Se, H, Le, and X gene-encoded glycosyltransferases in normal and malignant bladder urothelium. Cancer Res. 1988 Aug 1;48(15):4427–4433. [PubMed] [Google Scholar]
  18. Richie J. P., Blute R. D., Jr, Waisman J. Immunologic indicators of prognosis in bladder cancer: the importance of cell surface antigens. J Urol. 1980 Jan;123(1):22–24. doi: 10.1016/s0022-5347(17)55757-2. [DOI] [PubMed] [Google Scholar]
  19. Sakamoto J., Furukawa K., Cordon-Cardo C., Yin B. W., Rettig W. J., Oettgen H. F., Old L. J., Lloyd K. O. Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines. Cancer Res. 1986 Mar;46(3):1553–1561. [PubMed] [Google Scholar]
  20. Sakamoto J., Yin B. W., Lloyd K. O. Analysis of the expression of H, Lewis, X, Y and precursor blood group determinants in saliva and red cells using a panel of mouse monoclonal antibodies. Mol Immunol. 1984 Nov;21(11):1093–1098. doi: 10.1016/0161-5890(84)90119-6. [DOI] [PubMed] [Google Scholar]
  21. Sakamoto S., Watanabe T., Tokumaru T., Takagi H., Nakazato H., Lloyd K. O. Expression of Lewisa, Lewisb, Lewisx, Lewisy, siayl-Lewisa, and sialyl-Lewisx blood group antigens in human gastric carcinoma and in normal gastric tissue. Cancer Res. 1989 Feb 1;49(3):745–752. [PubMed] [Google Scholar]
  22. Thorpe S. J., Abel P., Henderson D., Jones N., Feizi T. Expression of blood group antigens in urinary tract tumours: prospective fluorescence study using cryostat sections of fresh frozen tissues. J Clin Pathol. 1986 Nov;39(11):1165–1176. doi: 10.1136/jcp.39.11.1165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Watkins W. M. Biochemistry and Genetics of the ABO, Lewis, and P blood group systems. Adv Hum Genet. 1980;10:1-136, 379-85. doi: 10.1007/978-1-4615-8288-5_1. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES